Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Parkway Life Real Estate Investment ( (SG:C2PU) ) has issued an update.
Parkway Life Real Estate Investment Trust has announced a significant renewal of its Board of Directors, aimed at strengthening its governance and strategic direction. The appointment of Mr. Robin Hu Yee Cheng as Chairman and Mrs. Eng-Kwok Seat Moey as an Independent Director, along with the continued service of Ms. Theresa Goh Cheng Keow, highlights the company’s commitment to robust governance and sustainable growth. These changes are expected to enhance PLife REIT’s resilience and long-term value creation for its unitholders, reinforcing its reputation in the healthcare real estate investment sector.
The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.50 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.
More about Parkway Life Real Estate Investment
Parkway Life Real Estate Investment Trust (PLife REIT) is one of Asia’s largest listed healthcare real estate investment trusts, managing a portfolio valued at approximately S$2.46 billion. The company focuses on healthcare properties, reinforcing its position as a trusted entity within the healthcare real estate sector.
Average Trading Volume: 944,538
Technical Sentiment Signal: Strong Buy
Current Market Cap: S$2.69B
See more data about C2PU stock on TipRanks’ Stock Analysis page.